Simvastatin and other HMG-CoA reductase inhibitors on brain cholesterol levels in Alzheimer's disease.

Abstract

Alzheimer's disease, one of the most common forms of dementia, is a neurodegenerative disorder characterized by progressive cognitive decline and affects as many as 5.3 million people in United States alone. Both Alzheimer's and dementia have tripled the cost of health care for elderly people, amounting to about $148 billion each year. Although there have… (More)

Topics

Cite this paper

@article{Longenberger2011SimvastatinAO, title={Simvastatin and other HMG-CoA reductase inhibitors on brain cholesterol levels in Alzheimer's disease.}, author={Justin Longenberger and Zahoor Ahmad Shah}, journal={Current Alzheimer research}, year={2011}, volume={8 4}, pages={434-42} }